Reply: Comments on the Published Meta-Analysis of Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated Infections
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.